Saravanamoorthy Rajendran

8586345, Nov 19, 2013

Mar 21, 2011

13/052778

David G. Simpson - Mechanicsville VA, US
Gary L. Bowlin - Mechanicsville VA, US
Gary E. Wnek - Midlothian VA, US
Peter J. Stevens - N. Richland Hills TX, US
Marcus E. Carr - Midlothian TX, US
Jamil A. Matthews - Glen Allen VA, US
Saravanamoorthy Rajendran - East Haven CT, US

Virginia Commonwealth University Intellectual Property Foundation - Richmond VA

C07K 1/00
C12N 5/00
C12N 5/02
A61K 38/17
A61F 2/06

435273, 435398, 435399, 530356, 623 147

The invention is directed to formation and use of electroprocessed collagen, including use as an extracellular matrix and, together with cells, its use in forming engineered tissue. The engineered tissue can include the synthetic manufacture of specific organs or tissues which may be implanted into a recipient. The electroprocessed collagen may also be combined with other molecules in order to deliver substances to the site of application or implantation of the electroprocessed collagen. The collagen or collagen/cell suspension is electrodeposited onto a substrate to form tissues and organs.

20020090725, Jul 11, 2002

Nov 16, 2001

09/991373

David Simpson - Machanicsville VA, US
Gary Bowlin - Mechanicsville VA, US
Gary Wnek - Midlothian VA, US
Peter Stevens - N. Richland Hills TX, US
Marcus Carr - Midlothian VA, US
Jamil Matthews - Glen Allen VA, US
Saravanamoorthy Rajendran - Branford CT, US

A61F002/02

435/402000, 623/023720, 530/356000, 623/001410, 424/423000

The invention is directed to formation and use of electroprocessed collagen, including use as an extracellular matrix and, together with cells, its use in forming engineered tissue. The engineered tissue can include the synthetic manufacture of specific organs or tissues which may be implanted into a recipient. The electroprocessed collagen may also be combined with other molecules in order to deliver substances to the site of application or implantation of the electroprocessed collagen. The collagen or collagen/cell suspension is electrodeposited onto a substrate to form tissues and organs.

20040037813, Feb 26, 2004

May 28, 2003

10/447670

David Simpson - Mechanicsville VA, US
Gary Bowlin - Mechanicsville VA, US
Gary Wnek - Midlothian VA, US
Peter Stevens - Richland Hills TX, US
Marcus Carr - Midlothian VA, US
Jamil Matthews - Glen Allen VA, US
Saravanamoorthy Rajendran - East Haven CT, US

A61K045/00
A61K009/70
B32B027/12
B32B027/04

424/093700, 424/443000, 442/123000

The invention is directed to formation and use of electroprocessed collagen, including use as an extracellular matrix and, together with cells, its use in forming engineered tissue. The engineered tissue can include the synthetic manufacture of specific organs or tissues which may be implanted into a recipient. The electroprocessed collagen may also be combined with other molecules in order to deliver substances to the site of application or implantation of the electroprocessed collagen. The collagen or collagen/cell suspension is electrodeposited onto a substrate to form tissues and organs.

20060094651, May 4, 2006

Nov 3, 2004

10/980370

Cyrus Karkaria - Branford CT, US
Tracy Chen - Clinton CT, US
Rajeev Chillakuru - Chester CT, US
Gan Wei - Hamden CT, US
Saravanamoorthy Rajendran - Branford CT, US

A61K 38/18
A61K 31/724

514012000, 514058000

The present invention provides improved formulations comprising FGF-20, its fragments, derivatives, variants, homologs, analogs, or a combination thereof, and improved methods for production.

20080038352, Feb 14, 2008

Aug 21, 2007

11/842748

David Simpson - Mechanicsville VA, US
Gary Bowlin - Mechanicsville VA, US
Gary Wnek - Midlothian VA, US
Peter Stevens - N. Richland Hills TX, US
Marcus Carr - Midlothian VA, US
Jamil Matthews - Glen Allen VA, US
Saravanamoorthy Rajendran - East Haven CT, US

Virginia Commonwealth University Intellectual Property Foundation - Richmond VA
Nanomatrix, Inc. - Irving TX

A61K 9/14
A61K 35/12
A61P 41/00

424484000, 424093100, 424093700

The invention is directed to formation and use of electroprocessed collagen, including use as an extracellular matrix and, together with cells, its use in forming engineered tissue. The engineered tissue can include the synthetic manufacture of specific organs or tissues which may be implanted into a recipient. The electroprocessed collagen may also be combined with other molecules in order to deliver substances to the site of application or implantation of the electroprocessed collagen. The collagen or collagen/cell suspension is electrodeposited onto a substrate to form tissues and organs.

20220332755, Oct 20, 2022

Apr 20, 2022

17/724958

- Boston MA, US
Saravanamoorthy RAJENDRAN - Middletown CT, US
Ryan TEDSTONE - New Haven CT, US

C07K 1/34
C07K 16/18
C07K 16/06
B01D 61/58
B01D 69/08
B01D 71/10
B01D 71/34
B01D 71/56
B01D 71/68

Provided herein are methods of performing viral filtration on a fluid including a recombinant antibody, and the use of these methods in methods of manufacturing or producing the recombinant antibody.

20210317425, Oct 14, 2021

Mar 13, 2019

17/043464

- Boston MA, US
Meghan DEWITT - Madison CT, US
Siguang SUI - South Glastonbury CT, US
Saravanamoorthy RAJENDRAN - Long Valley NJ, US

C12N 9/16
C12N 5/071
C12P 21/00
C07K 1/22

A method of producing recombinant alkaline phosphatase comprising control of production parameters, particularly harvest clarified culture fluid (HCCF) and filtration pool (UFDF), to provide a defined total sialic acid content.

20180072769, Mar 15, 2018

Mar 23, 2016

15/558932

- New Haven CT, US
Saravanamoorthy Rajendran - Middletown CT, US
Ryan Tedstone - New Haven CT, US

ALEXION PHARMACEUTICALS, INC. - New Haven CT

C07K 1/34
C07K 16/18
B01D 71/56
B01D 69/08
B01D 71/10
B01D 71/34
B01D 71/68
B01D 61/58

Provided herein are methods of performing viral filtration on a fluid including a recombinant antibody, and the use of these methods in methods of manufacturing or producing the recombinant antibody.